Affimed Pb Ratio from 2010 to 2024

AFMD Stock  USD 3.00  0.38  14.50%   
Affimed NV's PB Ratio is increasing over the years with slightly volatile fluctuation. Overall, PB Ratio is expected to go to 1.87 this year. During the period from 2010 to 2024 Affimed NV PB Ratio annual values regression line had geometric mean of  2.14 and mean square error of  3.99. View All Fundamentals
 
PB Ratio  
First Reported
2010-12-31
Previous Quarter
1.46134357
Current Value
1.87
Quarterly Volatility
2.33838194
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Affimed NV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Affimed NV's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.8 M, Interest Expense of 1.8 M or Selling General Administrative of 13.8 M, as well as many indicators such as Price To Sales Ratio of 9.7, Dividend Yield of 0.0 or PTB Ratio of 1.87. Affimed financial statements analysis is a perfect complement when working with Affimed NV Valuation or Volatility modules.
  
Check out the analysis of Affimed NV Correlation against competitors.
For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.

Latest Affimed NV's Pb Ratio Growth Pattern

Below is the plot of the Pb Ratio of Affimed NV over the last few years. It is Affimed NV's PB Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Affimed NV's overall financial position and show how it may be relating to other accounts over time.
Pb Ratio10 Years Trend
Slightly volatile
   Pb Ratio   
       Timeline  

Affimed Pb Ratio Regression Statistics

Arithmetic Mean1.81
Geometric Mean2.14
Coefficient Of Variation129.46
Mean Deviation1.88
Median1.59
Standard Deviation2.34
Sample Variance5.47
Range6.9379
R-Value0.57
Mean Square Error3.99
R-Squared0.32
Significance0.03
Slope0.30
Total Sum of Squares76.55

Affimed Pb Ratio History

2024 1.87
2022 1.08
2021 4.27
2020 5.52
2019 4.06
2018 4.09
2017 1.59

About Affimed NV Financial Statements

Affimed NV stakeholders use historical fundamental indicators, such as Affimed NV's Pb Ratio, to determine how well the company is positioned to perform in the future. Although Affimed NV investors may analyze each financial statement separately, they are all interrelated. For example, changes in Affimed NV's assets and liabilities are reflected in the revenues and expenses on Affimed NV's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Affimed NV. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
PB Ratio 1.46  1.87 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Affimed NV is a strong investment it is important to analyze Affimed NV's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Affimed NV's future performance. For an informed investment choice regarding Affimed Stock, refer to the following important reports:
Check out the analysis of Affimed NV Correlation against competitors.
For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Affimed NV. If investors know Affimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Affimed NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.76)
Revenue Per Share
0.493
Quarterly Revenue Growth
(0.90)
Return On Assets
(0.49)
Return On Equity
(1.24)
The market value of Affimed NV is measured differently than its book value, which is the value of Affimed that is recorded on the company's balance sheet. Investors also form their own opinion of Affimed NV's value that differs from its market value or its book value, called intrinsic value, which is Affimed NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Affimed NV's market value can be influenced by many factors that don't directly affect Affimed NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Affimed NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Affimed NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Affimed NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.